Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note issued on Tuesday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Up 0.7 %

ENZ stock opened at $0.71 on Tuesday. Enzo Biochem has a 52 week low of $0.68 and a 52 week high of $1.50. The firm has a 50 day moving average of $1.08 and a 200 day moving average of $1.11.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings data on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative net margin of 81.73% and a negative return on equity of 11.84%.

Hedge Funds Weigh In On Enzo Biochem

Several hedge funds and other institutional investors have recently bought and sold shares of ENZ. Geode Capital Management LLC lifted its stake in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares during the period. BBR Partners LLC acquired a new position in Enzo Biochem during the third quarter valued at $112,000. XTX Topco Ltd boosted its holdings in Enzo Biochem by 94.5% in the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 13,735 shares during the last quarter. Finally, Renaissance Technologies LLC grew its position in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after purchasing an additional 64,417 shares during the period. Institutional investors and hedge funds own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.